Insurance

TL/DR - The Burman family, which owns over 25% of Religare Ltd through four associate firms, has threatened legal action against the board of Care Health, the largest subsidiary of Religare. The Burmans allege that the Care Health board granted 22.7 million stock options to the non-executive chairperson of Care Health, Rashmi Saluja, despite the…

TL/DR - The Illinois House of Representatives has passed the “Healthcare Protection Act” that curbs some practices used by health insurance companies to control health care services costs. The bill bans the practice of step therapy in prescription drug plans, prohibits insurers from requiring prior authorization before covering in-patient…

TL/DR - Shriram Life Insurance's core target segment is the lower income bracket, whose customers typically prefer guaranteed returns and savings products, according to Casparus Kromhout, the company's CEO. Shriram's average premium size is INR 20,000 ($270), and it has not experienced an impact from the taxation of traditional plans for premiums…

TL/DR - A new report by HealthView Services has highlighted a substantial hike in 2024 premiums for Medicare Part D prescription drug plans in five US states, contradicting earlier predictions by the Centers for Medicare & Medicaid Services that these would decline due to the Inflation Reduction Act. The report shows retirees using Part D…